These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6573138)

  • 21. Mast cells: Part II.
    Berman BA; Ross RN
    Cutis; 1984 May; 33(5):448, 450, 452 passim. PubMed ID: 6434237
    [No Abstract]   [Full Text] [Related]  

  • 22. Prevention of allergic inflammation by a novel prostaglandin receptor antagonist, S-5751.
    Arimura A; Yasui K; Kishino J; Asanuma F; Hasegawa H; Kakudo S; Ohtani M; Arita H
    J Pharmacol Exp Ther; 2001 Aug; 298(2):411-9. PubMed ID: 11454901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of inflammatory mediators in allergic rhinitis.
    Naclerio R; Proud D; Peters S; Sobotka AK; Lichtenstein L; Norman P
    Ear Nose Throat J; 1986 May; 65(5):206-12. PubMed ID: 3459645
    [No Abstract]   [Full Text] [Related]  

  • 24. A double-masked comparison of ocular decongestants as therapy for allergic conjunctivitis.
    Lanier BQ; Tremblay N; Smith JP; deFaller JM
    Ann Allergy; 1983 Mar; 50(3):174-7. PubMed ID: 6338768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased formation of thromboxane in vivo in humans with mastocytosis.
    Morrow JD; Oates JA; Roberts LJ; Zackert WE; Mitchell TA; Lazarus G; Guzzo C
    J Invest Dermatol; 1999 Jul; 113(1):93-7. PubMed ID: 10417625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production.
    Butterfield JH; Weiler CR
    Int Arch Allergy Immunol; 2008; 147(4):338-43. PubMed ID: 18622141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical significance of perilimbal conjunctival pigmentation in vernal conjunctivitis.
    Khan FA; Khan Niazi SP; Awan S
    J Coll Physicians Surg Pak; 2012 Jan; 22(1):19-22. PubMed ID: 22237184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial.
    Borazan M; Karalezli A; Akova YA; Akman A; Kiyici H; Erbek SS
    Acta Ophthalmol; 2009 Aug; 87(5):549-54. PubMed ID: 18631332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secretory diarrhea and prostaglandin D2 overproduction in systemic mastocytosis.
    Poynard T; Nataf C; Messing B; Modigliani R; Lecompte T; Nicolas P; Dray F; Ferme C
    N Engl J Med; 1982 Jul; 307(3):186. PubMed ID: 6953312
    [No Abstract]   [Full Text] [Related]  

  • 30. [IS VERNAL CONJUNCTIVITIS OF ALLERGIC NATURE?].
    BLAMOUTIER P
    Bull Mem Soc Fr Ophtalmol; 1963; 76():475-7. PubMed ID: 14174251
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of desloratadine on conjunctival allergen challenge-induced ocular symptoms.
    Torkildsen GL; Gomes P; Welch D; Gopalan G; Srinivasan S
    Clin Exp Allergy; 2009 Jul; 39(7):1052-9. PubMed ID: 19302250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vernal conjunctivitis and contact lens-associated giant papillary conjunctivitis compared and contrasted.
    Allansmith MR; Baird RS; Greiner JV
    Am J Ophthalmol; 1979 Apr; 87(4):544-55. PubMed ID: 443320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vernal conjunctivitis as an atopic disease.
    ALLANSMITH M
    Calif Med; 1961 Sep; 95(3):163-4. PubMed ID: 13682482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical course and treatment of vernal conjunctivitis (author's transl)].
    Lisch K
    Klin Monbl Augenheilkd; 1980 May; 176(5):826-9. PubMed ID: 6108383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Shock syndrome associated with mastocytosis: pharmacologic reversal of the acute episode and therapeutic prevention of recurrent attacks.
    Roberts LJ; Turk JW; Oates JA
    Adv Shock Res; 1982; 8():145-52. PubMed ID: 7136941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vernal conjunctivitis in Nigerian children.
    Majekodunmi S
    J Pediatr Ophthalmol Strabismus; 1978; 15(3):176-8. PubMed ID: 739351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New therapeutic possibilities in vernal conjunctivitis].
    Popa DP; Papahagi V; Dinulescu A
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1984; 28(1):50-65. PubMed ID: 6145196
    [No Abstract]   [Full Text] [Related]  

  • 38. Component-resolved diagnostics in vernal conjunctivitis.
    Armentia A; Sanchís E; Montero JA
    Curr Opin Allergy Clin Immunol; 2016 Oct; 16(5):498-504. PubMed ID: 27454864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perilimbal bulbar conjunctival pigmentation in vernal conjunctivitis: prospective evaluation of a new clinical sign in an Indian population.
    Rao SK; Meenakshi S; Srinivasan B; Baluswamy S
    Cornea; 2004 May; 23(4):356-9. PubMed ID: 15097129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allergic conjunctivitis: update on pathophysiology and prospects for future treatment.
    Ono SJ; Abelson MB
    J Allergy Clin Immunol; 2005 Jan; 115(1):118-22. PubMed ID: 15637556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.